This proposal addresses a new approach to cancer treatment that may allow for selective killing of tumor cells regardless of their proliferative status, with potential for fully destroying the tumor. This approach is based on our functional genomic study that revealed that the expression of C0PZ2, a gene encoding a subunit of the coatomer protein complex I (COPI) is drastically decreased in the majority of the tested tumor cell lines and in human cancer tissues. The loss of C0PZ2 expression is a corollary of tumor-specific downregulation of a tumor-suppressive miRNA, miR-152. As a result of miR-152/COPZ2 downregulation, tumor cells become dependent on COPZ1, a gene that encodes an isoform of C0PZ2. While normal C0PZ2-expressing cells survive COPZ1 depletion, C0PZ2-deficient tumor cells are killed by COPZ1 knockdown. Cell death induced by COPZ1 inhibition is associated with Golgi fragmentation and, in contrast to the effects of almost all the anticancer drugs, is independent of cell proliferation. Hence, COPZ1-targeting therapy of miR152-deficient tumors has the potential for eradicating all the cancer cells in the body. We propose a set of specific aims to delineate the tumor-promoting effects of miR-152 down regulation and the frequency of miR-152/COPZ2 silencing in clinical cancers, and to investigate the potential toxicity of COPZ1 inhibition and the feasibility of targeting COPZ1 with small molecules.
In Aim 1, we will identify target genes of miR-152 and analyze their effects on tumor progression.
In Aim 2, we will analyze expression of COPZ1, C0PZ2, miR-152 and miR-152 target genes in clinical samples of malignant melanoma and prostate cancer.
In Aim 3, we will generate mice with homozygous or heterozygous knockout of COPZ1 to determine the deleterious effects of COPZ1 depletion. We will also develop and test prototype COPZ1-targeting small molecules through rational drug design. The success of this project will elucidate the spectrum and properties of miR-152-deficient tumors and provide proof of principle for the eradication of such tumors through therapeutic targeting of COPZ1.

Public Health Relevance

This proposal addresses a new approach to cancer treatment that may allow for selective killing of tumor cells regardless of their proliferative status, with potential for fully destroying the tumor, by attacking a novel molecular target, COPZ1. The proposed study will investigate the feasibility of COPZ1 targeting in cancer treatment and develop the first small-molecule COPZ1 inhibitors.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM109091-02
Application #
8885853
Study Section
Special Emphasis Panel (ZGM1-TWD-A)
Project Start
Project End
Budget Start
2015-05-01
Budget End
2016-04-30
Support Year
2
Fiscal Year
2015
Total Cost
$214,170
Indirect Cost
$64,170
Name
University of South Carolina at Columbia
Department
Type
DUNS #
041387846
City
Columbia
State
SC
Country
United States
Zip Code
29208
Liang, Jiaxin; Chen, Mengqian; Hughes, Daniel et al. (2018) CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases. Cancer Res 78:6594-6606
Chukwurah, Evelyn; Patel, Rekha C (2018) Stress-induced TRBP phosphorylation enhances its interaction with PKR to regulate cellular survival. Sci Rep 8:1020
Singh, Priyanka; Jenkins, Laura M; Horst, Ben et al. (2018) Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis. Cancer Res 78:2978-2989
Wyatt, Michael D; Reilly, Nicole M; Patel, Shikha et al. (2018) Thiopurine-induced mitotic catastrophe in Rad51d-deficient mammalian cells. Environ Mol Mutagen 59:38-48
Serrao, Anne; Jenkins, Laura M; Chumanevich, Alexander A et al. (2018) Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer. Oncogene 37:4792-4808
Varadaraj, Archana; Magdaleno, Carina; Mythreye, Karthikeyan (2018) Deoxycholate Fractionation of Fibronectin (FN) and Biotinylation Assay to Measure Recycled FN Fibrils in Epithelial Cells. Bio Protoc 8:
Liu, Changlong; Banister, Carolyn E; Weige, Charles C et al. (2018) PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids. Proc Natl Acad Sci U S A 115:E5066-E5075
Yu, Jin; Zhu, Hong; Taheri, Saeid et al. (2018) Impact of nutrition on inflammation, tauopathy, and behavioral outcomes from chronic traumatic encephalopathy. J Neuroinflammation 15:277
Jenkins, Laura M; Horst, Ben; Lancaster, Carly L et al. (2018) Dually modified transmembrane proteoglycans in development and disease. Cytokine Growth Factor Rev 39:124-136
Alam, Amer; Küng, Raphael; Kowal, Julia et al. (2018) Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1. Proc Natl Acad Sci U S A 115:E1973-E1982

Showing the most recent 10 out of 49 publications